What will you learn from the webinar ?
- Use of PET Imaging companion radiopharmaceutical in theranostics
Dr Bodei will give an introduction on the use of PET radiopharmaceuticals in Theranostic applications and she will provide a synopsis of the major clinical applications. She will also share future perspectives in this field.
- Evolving evidence-base for PSMA Theranostics to improve outcomes for men with prostate cancer
Prof. Hofman will deep dive into PSMA theranostics, a new treatment platform for men with advanced prostate cancer. He will explore the evolving evidence base, discuss different methodology for patient selection and treatment logistics.
When ? Jun 30, 2020 2:00 PM - 3:00 PM CEST